FDA Guidance On Combo HIV Products Will Allow Reviews In Six Weeks
Executive Summary
FDA is setting a goal of reviewing fixed-dose combinations of HIV drugs in six weeks as part of the Bush Administration's $15 bil. Emergency Plan for AIDS Relief
You may also be interested in...
Most Expedited Reviews For Generic HIV Drugs Are For Single Agents – FDA
FDA is expanding its program to expedite the review of fixed-dose combination and co-packaged HIV drugs to include single-ingredient copies of certain antiretroviral drugs, according to a recently released final guidance
Most Expedited Reviews For Generic HIV Drugs Are For Single Agents – FDA
FDA is expanding its program to expedite the review of fixed-dose combination and co-packaged HIV drugs to include single-ingredient copies of certain antiretroviral drugs, according to a recently released final guidance
Co-Packaged HIV Drug User Fees Likely To Be Waived By AIDS Relief Plan
Most fixed-dose combination and co-packaged versions of previously approved antiretroviral HIV therapies are unlikely to require user fees under the President's $15 bil. Emergency Plan for AIDS Relief, according to a 1draft guidance released April 15